Evidence map›Paper›PMID 32962663›Full record

ArticleBMC neurology2020

Dynamic-related protein 1 inhibitor eases epileptic seizures and can regulate equilibrative nucleoside transporter 1 expression.

Zhong Luo, Jing Wang, Shirong Tang, Yongsu Zheng, Xuejiao Zhou, Fei Tian, Zucai Xu

Open access · goldAbstract read
In one paragraph

Article in BMC neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Zhong LuoDepartment of Neurology, The Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Zunyi, 563003, Guizhou, China.
Jing WangDepartment of Neurology, The Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Zunyi, 563003, Guizhou, China.
Shirong TangDepartment of Neurology, The Thirteenth People's Hospital of Chongqing, Chongqing, 400053, China.
Yongsu ZhengDepartment of Neurology, The Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Zunyi, 563003, Guizhou, China.
Xuejiao ZhouDepartment of Neurology, The Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Zunyi, 563003, Guizhou, China.
Fei TianDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Zucai XuDepartment of Neurology, The Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Zunyi, 563003, Guizhou, China. docxzc@126.com.
Zunyi Medical University · CNCapital Medical University · CNThird People 's Hospital of Chongqing · CN

Funding

the Guizhou Province Health and Family Planning Commission Science and Technology Foundation gzwjkj 2015-1-052the Guizhou Province Science and Technology Cooperation Project [2015]7471the Guizhou Province Science and Technology Cooperation Project [2015] 7520the National Natural Science Foundation of China 81560224the National Natural Science Foundation of China 81660227the Zunyi City Science and Technology Foundation [2018]64
6 · The paper itself

Abstract

backgroundDynamic-related protein 1 (Drp1) is a key protein involved in the regulation of mitochondrial fission, and it could affect the dynamic balance of mitochondria and appears to be protective against neuronal injury in epileptic seizures. Equilibrative nucleoside transporter 1 (ENT1) is expressed and functional in the mitochondrial membrane that equilibrates adenosine concentration across membranes. Whether Drp1 participates in the pathogenesis of epileptic seizures via regulating function of ENT1 remains unclear.

methodsIn the present study, we used pilocarpine to induce status epilepticus (SE) in rats, and we used mitochondrial division inhibitor 1 (Mdivi-1), a selective inhibitor to Drp1, to suppress mitochondrial fission in pilocarpine-induced SE model. Mdivi-1administered by intraperitoneal injection before SE induction, and the latency to firstepileptic seizure and the number of epileptic seizures was thereafter observed. The distribution of Drp1 was detected by immunofluorescence, and the expression patterns of Drp1 and ENT1 were detected by Western blot. Furthermore, the mitochondrial ultrastructure of neurons in the hippocampal CA1 region was observed by transmission electron microscopy.

resultsWe found that Drp1 was expressed mainly in neurons and Drp1 expression was significantly upregulated in the hippocampal and temporal neocortex tissues at 6 h and 24 h after induction of SE. Mitochondrial fission inhibitor 1 attenuated epileptic seizures after induction of SE, reduced mitochondrial damage and ENT1 expression.

conclusionsThese data indicate that Drp1 is upregulated in hippocampus and temporal neocortex after pilocarpine-induced SE and the inhibition of Drp1 may lead to potential therapeutic target for SE by regulating ENT1 after pilocarpine-induced SE.

Indexed as

Status EpilepticusAnimalsBrainDynaminsEquilibrative Nucleoside Transporter 1MaleMitochondriaMitochondrial DynamicsNeuronsQuinazolinonesRatsRats, Sprague-Dawley3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinoneDnm1l protein, ratDynaminsEquilibrative Nucleoside Transporter 1QuinazolinonesDrp1ENT1Epileptic seizureMitochondriaSE

Identifiers

PMID32962663
PMCPMC7507736
OpenAlexW3089269666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.